Burns, SM; Cunningham, CW; Mercer, SL. DARK classics in chemical neuroscience: Fentanyl ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2428-2437. 1.4 MB. https://doi.org/10.1021/acschemneuro.8b00174 #Naloxone
Chambers, SA; DeSousa, JM; Huseman, ED; Townsend, SD. The DARK side of total synthesis: Strategies and tactics in psychoactive drug production ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2307–2330. 8.1 MB. https://doi.org/10.1021/acschemneuro.7b00528 #9
Kronstrand, R; Guerrieri, D; Vikingsson, S; Wohlfarth, A; Gréen, H. Fatal poisonings associated with new psychoactive substances In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 495–541. 477 kB. https://doi.org/10.1007/164_2018_110 #Naloxone
Armenian, P; Vo, KT; Barr-Walker, J; Lynch, KL. Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review Neuropharmacology, 1 May 2018, 134, 121–132. 847 kB. https://doi.org/10.1016/j.neuropharm.2017.10.016 #Naloxone
Devereaux, AL; Mercer, SL; Cunningham, CW. DARK classics in chemical neuroscience: Morphine ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2395-2407. 3.0 MB. https://doi.org/10.1021/acschemneuro.8b00150 #7, 16
Johnson, H. Quantitative stereo-structure activity relationships I. Opiate receptor binding In QuaSAR: Quantitative Structure Activity Relationships of Analgesics, Narcotic Antagonists, and Hallucinogens. NIDA Research Monograph 22; Barnett, G; Trsic, M; Willette, RE, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1 Jan 1978; Vol. 22, pp 146–158. 685 kB.